Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Nyrada Inc (AU: NYR)

 
NYR Technical Analysis
4
As on 1st Apr 2025 NYR STOCK Price closed @ 0.10 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.05 & Strong Buy for SHORT-TERM with Stoploss of 0.02 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NYRSTOCK Price

Open 0.11 Change Price %
High 0.11 1 Day -0.01 -9.09
Low 0.10 1 Week -0.01 -9.09
Close 0.10 1 Month 0.02 25.00
Volume 310551 1 Year 0.08 400.00
52 Week High 0.15 | 52 Week Low 0.02
 
AU Australia Most Active Stocks
WHK 0.03 200.00%
BTR 0.02 0.00%
CRS 0.06 -33.33%
JAY 0.00 %
ATH 0.01 0.00%
PLS 1.59 -5.36%
TLS 4.27 1.43%
PNR 0.16 -5.88%
CLA 0.01 %
OZM 0.09 50.00%
 
AU Australia Top Gainers Stocks
IXU 0.18 1700.00%
WHK 0.03 200.00%
APV 0.02 100.00%
FG1 0.03 50.00%
FG1 0.03 50.00%
FG1 0.03 50.00%
FG1 0.03 50.00%
FG1 0.03 50.00%
INF 0.03 50.00%
INF 0.03 50.00%
 
AU Australia Top Losers Stocks
RDN 0.00 -100.00%
RDN 0.00 -100.00%
RDN 0.00 -100.00%
RDN 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
AX8 0.00 -100.00%
 
 
NYR
Daily Charts		 NYR
Intraday Charts		 Whats New @
Bazaartrend		 NYR
Free Analysis
 
NYR Important Levels Intraday
RESISTANCE0.12
RESISTANCE0.11
RESISTANCE0.11
RESISTANCE0.11
SUPPORT0.09
SUPPORT0.09
SUPPORT0.09
SUPPORT0.08
 
NYR Forecast April 2025
Share
4th UP Forecast0.12
3rd UP Forecast0.11
2nd UP Forecast0.11
1st UP Forecast0.11
1st DOWN Forecast0.09
2nd DOWN Forecast0.09
3rd DOWN Forecast0.09
4th DOWN Forecast0.08
 
NYR Weekly Forecast
4th UP Forecast0.10
3rd UP Forecast0.10
2nd UP Forecast0.10
1st UP Forecast0.10
1st DOWN Forecast0.10
2nd DOWN Forecast0.10
3rd DOWN Forecast0.10
4th DOWN Forecast0.10
 
NYR Forecast2025
4th UP Forecast0.39
3rd UP Forecast0.3
2nd UP Forecast0.24
1st UP Forecast0.18
1st DOWN Forecast0.02
2nd DOWN Forecast-0.04
3rd DOWN Forecast-0.1
4th DOWN Forecast-0.19
 
 
NYR Other Details
Segment EQ
Market Capital 39782292.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NYR Address
NYR
 
NYR Latest News
 
Your Comments and Response on Nyrada Inc
 
NYR Business Profile
Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in the drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; NYR-BI01, a neuroprotectant drug, to reduce the disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. The company has collaboration with Walter Reed Army Institute of Research and University of New South Wales, Sydney for advancement of preclinical neuroprotection compound for traumatic brain injury. Nyrada Inc. was incorporated in 2017 and is based in Gordon, Australia. Address: 828 Pacific Highway, Gordon, NSW, Australia, 2072
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service